Pre-Open Stock Movers 05/03: (MDP) (OCGN) (VIRX) Higher; (VXRT) (PETS) (EL) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Vaxart (VXRT) Reports First Patient Enrollment in Phase 1b Norovirus Boosting Regimen Study
May 5, 2021 6:20 AM EDTVaxart, Inc. (NASDAQ: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it has enrolled the first subject in a Phase 1b boosting regimen trial of its norovirus vaccine candidate. This study is designed to evaluate the safety and immunogenicity of various dosing intervals for Vaxarts candidate, which is the only clinical stage norovirus oral tablet vaccine actively being developed.
In a health economic study published in the American Journal of Preventative Medicine in January... More
Clorox (CLX) PT Lowered to $195 at Jefferies
May 4, 2021 6:00 AM EDTJefferies analyst Kevin Grundy lowered the price target on Clorox (NYSE: CLX) to $195.00 (from $205.00) while maintaining a Hold rating.
The analyst comments "We trim our FY22-23 EPS ests.... More
